You need to be logged in to view this video

Unlocking the Pharmaceutical Potential of Cannabinoids

Released on Thursday, February 18, 2021BIOTECH
Skye Bioscience is working to solve the world's leading cause of irreversible blindness, applying advanced science to unlock the therapeutic potential of cannabinoids and create important new pharmaceutical medicines. Preclinical data suggest that Skye Bioscience may have advantages over leading commercially available drugs, including a mechanism to protect against vision loss that no other drugs on the market can claim. New insights from key near-term catalysts are expected to be impactful in delineating the therapeutic and commercial potential of Skye's lead drug.

Punit Dhillon
Skye Bioscience, CEO and Chair

Trending Now

Filter By Category
Filter By Keywords